Subscribe to MDT Magazine News

Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments

March 11, 2011 4:35 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 11, 2011 /- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) today reported financial results for the fourth quarter and full year ended December 31, 2010, and reviewed recent developments. "Our focus is working with Eisai to obtain FDA approval of lorcaserin, preparing to...


Qforma Appoints Two New Executives

March 11, 2011 4:35 am | by Bio-Medicine.Org | Comments

SANTA FE, N.M., March 11, 2011 /- Qforma, an advanced analytics and predictive modeling company, today announced the appointments of Elna Hamp to Vice President, Business Development and Joann Flynn to Marketing Manager. "As our clients' business models continue to evolve with the...


Woman Files Suit in Beaumont, Texas Federal Court Against DePuy Orthopaedics and Johnson & Johnson Over Recalled Hip Device

March 11, 2011 4:33 am | by Bio-Medicine.Org | Comments

LIBERTY, Texas, March 10, 2011 /- Donna L. Jenkins filed suit today in the United States District Court in Beaumont, Texas, over a failed hip replacement system from Johnson & Johnson, Inc. and DePuy Orthopaedics that was recalled from the market.  John David Hart of the Law...


Sonitus Medical Receives European CE Mark for SoundBiteâ„¢ Hearing System

March 11, 2011 3:35 am | by Bio-Medicine.Org | Comments

SAN MATEO, Calif., March 11, 2011 /- Sonitus Medical, Inc., a medical device company that manufactures the world's first non-surgical and removable hearing prosthetic to transmit sound via the teeth, today announced that it has received CE Mark certification for its SoundBite Hearing...


Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer

March 11, 2011 3:34 am | by Bio-Medicine.Org | Comments

PARIS and TARRYTOWN, N.Y., March 10, 2011 /- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today announced results from the Phase III VITAL trial evaluating the investigational agent aflibercept (VEGF Trap) for the second-line treatment...


Mindray Medical to Present at the 14th Annual Credit Suisse Asian Investment Conference on March 21-25

March 11, 2011 3:33 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, March 11, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will present at the 14th Annual Credit Suisse Asian Investment Conference,...


Simple blood test detects early emphysema in smokers before symptoms appear

March 10, 2011 8:33 pm | by EurekAlert | Comments

(New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College) During a regular annual physical exam, blood is usually drawn to check the health of a person's heart, kidneys and liver. Now, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical...


Colibrys SA strengthens its presence in China

March 10, 2011 7:36 pm | by I-Micronews | Comments

Neuchatel, Switzerland: Colibrys signed today an agency agreement with NAV Technology Co., Ltd. based in Beijing, China for its MEMS accelerometers within China.


Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.

March 10, 2011 7:33 pm | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, March 11, 2011 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) announced that effective March 10, 2011, the company completed its previously announced acquisition of PharmaSwiss S.A. About Valeant Valeant Pharmaceuticals International, Inc....


Emergent BioSolutions 4Q profit surges on BioThrax

March 10, 2011 1:45 pm | by The Associated Press | Comments

Emergent BioSolutions Inc. said Thursday its fourth-quarter profit surged on sales of its anthrax treatment BioThrax.The company earned $26.2 million, or 76 cents per share, compared with $4.2 million, or 13 cents per share, during the same period a year prior. Revenue nearly doubled to $103.2...

Given Imaging gets expanded approval for PillCam

March 10, 2011 12:45 pm | by The Associated Press | Comments

Given Imaging Ltd., an Israeli maker of pill-sized diagnostic cameras, said Thursday its swallowable PillCam camera received expanded Food and Drug Administration approval.The device was already approved for use in colonoscopies and other procedures. It is now approved for monitoring lesions that...

Brain cell regrowth linked to benefits of exercise, sexual behaviors and reproductive issues

March 10, 2011 12:37 pm | by EurekAlert | Comments

(Cell Transplantation Center of Excellence for Aging and Brain Repair) Recent research confirms that adult brain cells can regenerate. Two studies explore links between neurogenesis of key adult brain cells in two critical areas of the brain -- the hippocampus and subventricular...


Trapping prostate cancer cells to keep them from spreading provides hope

March 10, 2011 12:37 pm | by EurekAlert | Comments

(Cell Transplantation Center of Excellence for Aging and Brain Repair) When prostate cancer stem cells (CSCs) were enclosed in self-assembling nanomaterials made of peptides (SAP), the SAPs stopped cancer stem cell colony formation and also stopped the division of cancer cells in...


'Probiotics and Health Claims'

March 10, 2011 10:37 am | by EurekAlert | Comments

(Wiley-Blackwell) New title explores the scientific basis for the health benefits of "friendly bacteria" and how those claims are regulated.


Vertex plans to grow epilepsy drug trial

March 10, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Vertex Pharmaceuticals Inc. said it will conduct a broader trial of a potential drug against epilepsy following positive results in a Phase 2 study.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.